Check order status

Become part of a community of book lovers from all over the world and get access to a whole bunch of benefits. Create an account for free

Austrian Post 5.49 € DPD courier 3.99 € DPD point 2.99 €

Contact

How to shop

Help

My account

▸ Empty :-(

Structural Genomics, Part A

Name: Structural Genomics, Part A
Brand: Elsevier Science Publishing Co Inc
SKU: 04494161
Price: 162.89 EUR
Availability: InStock
Author: Andrzej Joachimiak
ISBN: 9780123744364

Andrzej Joachimiak

Language

English

Book Hardback

Libristo code: 04494161

Publishers Elsevier Science Publishing Co Inc, December 2008

Structural genomics is the systematic determination of 3-dimensional structures of proteins represen... Full description

Libristo code: 04494161

399 b

162.89 € VAT included

Print on demand Shipping in 28-34 days

Delivery to Austria

30-day return policy

Customers also purchased

Momentos de sabiduria ALVARO SANTOS

Paperback

4.29 €

Carmina: Latin Text Horace

Paperback

8.89 €

Effektivitaet Der Sprachfoerderung Ein- Und Mehrsprachiger Kinder in Vorschulischen Einrichtungen Detta Sophie Schütz

Hardback

76.09 €

Structural genomics is the systematic determination of 3-dimensional structures of proteins representative of the range of protein structure and function found in nature. The goal is to build a body of structural information that will predict the structure and potential function for almost any protein from knowledge of its coding sequence. This is essential information for understanding the functioning of the human proteome, the ensemble of tens of thousands of proteins specified by the human genome. While most structural biologists pursue structures of individual proteins or protein groups, specialists in structural genomics pursue structures of proteins on a genome wide scale. This implies large scale cloning, expression and purification. One main advantage of this approach is economy of scale.This book examines the three dimensional structure of all proteins of a given organism, by experimental methods such as X-ray crystallography and NMR spectroscopy. It looks at structural genomics as a foundation of drug discovery as discovering new medicines is becoming more challenging and the pharmaceutical industry is looking to new technologies to help in this mission.